For lung cancer, we collect the status of the National Comprehensive Cancer Network (NCCN) recommended biomarkers: EGFR, ALK, BRAF, ROS1, KRAS, RET, NTRK and PD-L1. This evidence concerns the gene ROS1 and lung carcinoma.